BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 29681621)

  • 1. Circulating cell-free nucleic acids: characteristics and applications.
    Pös O; Biró O; Szemes T; Nagy B
    Eur J Hum Genet; 2018 Jul; 26(7):937-945. PubMed ID: 29681621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free DNA diagnostics: current and emerging applications in oncology.
    Muluhngwi P; Valdes R; Fernandez-Botran R; Burton E; Williams B; Linder MW
    Pharmacogenomics; 2019 Apr; 20(5):357-380. PubMed ID: 30983510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biocomposite-based rapid sampling assay for circulating cell-free DNA in liquid biopsy samples from human cancers.
    Koo B; Jun E; Liu H; Kim EJ; Park YY; Lim SB; Kim SC; Shin Y
    Sci Rep; 2020 Sep; 10(1):14932. PubMed ID: 32913285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in circulating nucleic acids in oncology.
    Otandault A; Anker P; Al Amir Dache Z; Guillaumon V; Meddeb R; Pastor B; Pisareva E; Sanchez C; Tanos R; Tousch G; Schwarzenbach H; Thierry AR
    Ann Oncol; 2019 Mar; 30(3):374-384. PubMed ID: 30753271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
    Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
    Zeng H; He B; Yi C; Peng J
    J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy: A new avenue in pathology.
    Ghosh RK; Pandey T; Dey P
    Cytopathology; 2019 Mar; 30(2):138-143. PubMed ID: 30485558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
    Kahlert C
    Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Free DNA: Applications in Different Diseases.
    Ranucci R
    Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor DNA in liquid biopsy: Current diagnostic limitation.
    Liu SC
    World J Gastroenterol; 2024 Apr; 30(15):2175-2178. PubMed ID: 38681986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Cancer Therapy: Liquid Biopsy.
    Marmé D
    Oncol Res Treat; 2017; 40(7-8):402-403. PubMed ID: 28728143
    [No Abstract]   [Full Text] [Related]  

  • 16. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
    Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
    Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
    Tomasetti M; Amati M; Neuzil J; Santarelli L
    Lung Cancer; 2017 May; 107():65-72. PubMed ID: 27312601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsy: Emergence of an Alternative Cancer Detection Method.
    Law EW; Settell ML; Kurani SS; Eckert EC; Liu MC; Greenberg-Worisek AJ
    Clin Transl Sci; 2020 Sep; 13(5):845-847. PubMed ID: 32233063
    [No Abstract]   [Full Text] [Related]  

  • 19. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of commercial kits for purification of circulating free DNA.
    Diefenbach RJ; Lee JH; Kefford RF; Rizos H
    Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.